Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pfizer Inc PFE

Alternate Symbol(s):  N.PFE

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the... see more

Recent & Breaking News (NYSE:PFE)

Pfizer Declares First-Quarter 2017 Dividend

Business Wire December 12, 2016

8 Of The Biggest Biotech Announcements Out Of The 2016 ASH Meeting

Benzinga.com  December 6, 2016

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Business Wire December 6, 2016

The Medicines Company Is A Major Cardiovascular Player In The Making

Benzinga.com  December 5, 2016

Pfizer and Avillion Announce Positive Top-Line Results for Phase 3 BFORE Study of BOSULIF for First-Line Treatment of Philadelphia Chromosome Positive Chronic Myeloid Leukemia

Business Wire December 5, 2016

New Phase 2 Results Show Investigational Compound Glasdegib Improved Overall Survival in Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Business Wire December 3, 2016

Spark Therapeutics and Pfizer Present Updated Preliminary Data from Hemophilia B Phase 1/2 Trial Suggesting Consistent and Sustained Levels of Factor IX Activity at Annual ASH Meeting

GlobeNewswire December 3, 2016

The Market In 5 Minutes: Payrolls, Smith & Wesson Earnings And Starbucks' CEO Change

Benzinga.com  December 2, 2016

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

Business Wire December 1, 2016

Biotech Sector Growth Expected Upon Diminishing Concerns Over Drug Pricing

PR Newswire December 1, 2016

LYRICA® (pregabalin) Phase 3 Trial in Pediatric Epilepsy Meets Primary Endpoint

Business Wire December 1, 2016

IBM and Pfizer to Accelerate Immuno-oncology Research with Watson for Drug Discovery

PR Newswire December 1, 2016

Omnicell's Performance Center Integrates with Hospira's Infusion Pump Software

PR Newswire November 30, 2016

Pfizer Announces Positive Top-Line Results from the Pivotal Comparative REFLECTIONS B3271002 Study for PF-05280014, a Potential Biosimilar to Herceptin®1 (trastuzumab)

Business Wire November 30, 2016

Barclays Downgrades 5 Biopharma Stocks, Upgrades Pfizer And Alexion

Benzinga.com  November 29, 2016

FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review

PR Newswire November 29, 2016

Innovative Clinical Trial Implementation and Manufacturing Capacity Production Fueling Biotech Sector Growth

PR Newswire November 28, 2016

Anthony J. Maddaluna, Executive Vice President and President of Pfizer Global Supply to Retire

Business Wire November 21, 2016

Pfizer Announces Expiration And Results Of Tender Offer For Any And All Of Its 6.200% Senior Notes Due March 15, 2019

Business Wire November 21, 2016

Pfizer Announces Pricing of Tender Offer for Any and All of its 6.200% Senior Notes Due March 15, 2019

Business Wire November 18, 2016